Home Newsfeeds HC Wainwright & Co. Downgrades Meridian Bioscience to Neutral, Raises Price Target to $34

HC Wainwright & Co. Downgrades Meridian Bioscience to Neutral, Raises Price Target to $34

HC Wainwright & Co. analyst Yi Chen downgrades Meridian Bioscience (NASDAQ:VIVO) from Buy to Neutral and raises the price target from $30 to $34.

byBenzinga Newsdesk

July 8, 2022

1 minute read

HC Wainwright & Co. analyst Yi Chen downgrades Meridian Bioscience (NASDAQ:VIVO) from Buy to Neutral and raises the price target from $30 to $34.

News

Fisker To Commence Volume Deliveries Of Fisker Ocean Week Of June 19 In United States

By Happy Mohamed

June 1, 12:16 PM

Fisker will start volume deliveries to US customers the week of June 19 The EPA confirmed in May that the Fisker Ocean has a range of 360 miles Fisker Inc. (NYSE:FSR) ("Fisker"), driven by a mission

FSR

Several Airlines Hit Pause On Tel Aviv Amid Rising Tensions: Report

By Shivani Kumaresan

October 9, 6:02 AM

In response to the recent Hamas militant assault on Israel, numerous global airlines have reportedly suspended their flights to Tel Aviv, citing security concerns, and will await safer conditions before restarting their services.

AAL

News

Why Bullfrog AI (BFRG) Stock Is Exploding Higher Tuesday

By Henry Khederian

April 4, 10:31 AM

Bullfrog AI Holdings, Inc. (NASDAQ: BFRG) shares are trading higher by 88.70% to $8.85 Tuesday morning after the company announced a worldwide license agreement with Johns Hopkins University Applied Physics Laboratory for use of patented technology powering the company's bfLEAP platform.

BFRG